Company Profile

Nantong Jinghua Pharmaceutical Co.,Ltd.
Year Established : 1957
Total Number of Staff : 100-500
Main Competitive Advantages : Brand Name,International Approvals/Standards,Production Capacity,Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages : Competitive GMP quality system for APIs, approved by US FDA, TGA, COFEPRIS, with Chinese GMP. Five APIs have CEP certificate.
  • Contact Person :
  • Fax:

Nantong Jinghua Pharmaceutical Co.,Ltd is a public pharmaceutical company in China that was established in 1957, owning about 302 staffs, located in No. 20, 3 Haibin Road, Yanhai Economic Development Zone, Rudong, Nantong,Jiangsu, China. We are appointed as a high-new-technical enterprise by Jiangsu Scientific technological Bureau.

 

As a comprehensive, advanced and innovative GMP company, we focus on manufacture, R&D and sales of APIs, pharmaceutical intermediates. Our company produce Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil etc., in which the fist five products have CEP certificates.

 

The advantage of our company

 

  1.   A Global Corporation

We have a long and stable corporation with many world-famous pharmaceutical companies, like Sanofi, Novartis, Teva and etc.

  1.   Well-established Quality Management System

Successful official inspections from Chinese FDA, US FDA, TGA and 3rd party inspections.

  1.   International registration

Our products are registered in many countries and get legal marketing rights to these countries, such as America, Canada, Europe, Russia, Japan and so on.

  1.   Innovation R&D

A strong R&D team that committed to developing medicine which ensures our leadership in APIs manufacture.

As a diversified company, our core values are driven by a desire to” Value life, boost health”, we strive to help create a healthier, brighter future for people around the world.

PharmaSources Customer Service